Annual EBITDA
$1.07B$43.00M+4.19%
Summary
- Current Value
- As of today, HSIC annual EBITDA is $1.07B, up +4.19% on
- Historical Performance
- HSIC annual EBITDA is down -7.04% over the past 3 years, up +41.98% over the past 5 years
- All-Time High Comparison
- HSIC annual EBITDA is currently -7.04% below its historical high of $1.15B set on
- 3-Year Low Comparison
- HSIC annual EBITDA is +11.12% above its 3-year low of $962.00M reached on
- Sector Comparison
- HSIC annual EBITDA is higher than 93.19% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.07B | +4.2% | -7.0% | +42.0% | +67.8% | |
| Quarterly EBITDA | $301.00M | +5.2% | +7.5% | +14.8% | +75.2% | |
| TTM EBITDA | $1.16B | +6.9% | +9.0% | +11.3% | +71.6% | |
| Price | $86.22 | +17.6% | +27.7% | +8.8% | +233.7% | |
| PE Ratio | 23.59 | +1.8% | +17.4% | +29.2% | +74.3% | |
| Annual Revenue | $13.18B | +4.0% | +4.3% | +30.3% | +75.2% | |
| Annual EPS | $3.27 | +7.1% | -16.3% | +16.6% | +87.4% | |
| $758.00M | +4.0% | -19.2% | +33.6% | +41.5% | ||
| Annual Net Income | $419.00M | +5.3% | -26.0% | +0.5% | +19.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.15B | N/A | -7.0% |
| 5Y | $1.15B | -7.0% | |
| All | $1.15B | -7.0% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $962.00M | +11.1% | |
| 5Y | $752.93M | N/A | +42.0% |
| All | -$5.70M | >+9999.0% |
EBITDA History
FAQ
- What is the current annual EBITDA of HSIC?
- As of today, HSIC annual EBITDA is $1.07B
- What is 1-year change in HSIC annual EBITDA?
- HSIC annual EBITDA is up +4.19% year-over-year
- What is 3-year change in HSIC annual EBITDA?
- HSIC annual EBITDA is down -7.04% over the past 3 years
- How far is HSIC annual EBITDA from its all-time high?
- HSIC annual EBITDA is currently -7.04% below its historical high of $1.15B set on December 31, 2022
- How does HSIC annual EBITDA rank versus sector peers?
- HSIC annual EBITDA is higher than 93.19% of companies in Healthcare sector
- When is HSIC next annual earnings release?
- The next annual earnings release for HSIC is on
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$301.00M$16.00M+5.61%
Summary
- Current Value
- As of today, HSIC quarterly EBITDA is $301.00M, up +5.61% on
- Historical Performance
- HSIC quarterly EBITDA is up +5.24% year-over-year, up +7.50% over the past 3 years
- All-Time High Comparison
- HSIC quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- HSIC quarterly EBITDA is +135.16% above its 3-year low of $128.00M reached on
- Sector Comparison
- HSIC quarterly EBITDA is higher than 92.44% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $301.00M | +5.6% | +5.2% | +7.5% | +14.8% | |
| Annual EBITDA | $1.07B | – | +4.2% | -7.0% | +42.0% | |
| TTM EBITDA | $1.16B | +1.3% | +6.9% | +9.0% | +11.3% | |
| Price | $86.22 | -4.3% | +17.6% | +27.7% | +8.8% | |
| PE Ratio | 23.59 | -10.2% | +1.8% | +17.4% | +29.2% | |
| Quarterly Revenue | $3.47B | +0.4% | +4.0% | +9.8% | +9.2% | |
| Quarterly EPS | $1.06 | +28.7% | +26.7% | +1.4% | -3.7% | |
| $215.00M | +7.0% | +4.4% | +1.9% | +2.1% | ||
| Quarterly Net Income | $126.00M | +23.5% | +15.6% | -11.9% | -22.3% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $301.00M | at high | |
| 3Y | $301.00M | at high | |
| 5Y | $301.00M | at high | |
| All | $301.00M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $279.00M | +7.9% | |
| 3Y | $128.00M | +135.2% | |
| 5Y | $128.00M | +135.2% | |
| All | -$398.30M | +175.6% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of HSIC?
- As of today, HSIC quarterly EBITDA is $301.00M
- What is HSIC quarterly EBITDA most recent change?
- HSIC quarterly EBITDA was up +5.61% on September 26, 2026
- What is 1-year change in HSIC quarterly EBITDA?
- HSIC quarterly EBITDA is up +5.24% year-over-year
- How far is HSIC quarterly EBITDA from its all-time high?
- HSIC quarterly EBITDA is currently at its all-time high
- How does HSIC quarterly EBITDA rank versus sector peers?
- HSIC quarterly EBITDA is higher than 92.44% of companies in Healthcare sector
- When is HSIC next earnings release?
- The next earnings release for HSIC is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$1.16B$15.00M+1.32%
Summary
- Current Value
- As of today, HSIC TTM EBITDA is $1.16B, up +1.32% on
- Historical Performance
- HSIC TTM EBITDA is up +6.94% year-over-year, up +8.96% over the past 3 years
- All-Time High Comparison
- HSIC TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- HSIC TTM EBITDA is +30.07% above its 3-year low of $888.00M reached on
- Sector Comparison
- HSIC TTM EBITDA is higher than 92.83% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.16B | +1.3% | +6.9% | +9.0% | +11.3% | |
| Annual EBITDA | $1.07B | – | +4.2% | -7.0% | +42.0% | |
| Quarterly EBITDA | $301.00M | +5.6% | +5.2% | +7.5% | +14.8% | |
| Price | $86.22 | -4.3% | +17.6% | +27.7% | +8.8% | |
| PE Ratio | 23.59 | -10.2% | +1.8% | +17.4% | +29.2% | |
| TTM Revenue | $13.73B | +1.0% | +6.2% | +8.2% | +12.2% | |
| TTM EPS | $3.65 | +6.5% | +15.5% | +8.8% | -15.8% | |
| $822.00M | +1.1% | +6.1% | -0.7% | -2.1% | ||
| TTM Net Income | $443.00M | +4.0% | +7.5% | -5.7% | -31.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.16B | at high | |
| 3Y | $1.16B | at high | |
| 5Y | $1.16B | at high | |
| All | $1.16B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.08B | N/A | +6.9% |
| 3Y | $888.00M | +30.1% | |
| 5Y | $888.00M | +30.1% | |
| All | -$370.50M | +411.7% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of HSIC?
- As of today, HSIC TTM EBITDA is $1.16B
- What is HSIC TTM EBITDA most recent change?
- HSIC TTM EBITDA was up +1.32% on September 26, 2026
- What is 1-year change in HSIC TTM EBITDA?
- HSIC TTM EBITDA is up +6.94% year-over-year
- How far is HSIC TTM EBITDA from its all-time high?
- HSIC TTM EBITDA is currently at its all-time high
- How does HSIC TTM EBITDA rank versus sector peers?
- HSIC TTM EBITDA is higher than 92.83% of companies in Healthcare sector
- When is HSIC next earnings release?
- The next earnings release for HSIC is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- HSIC Official Website www.henryschein.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1000228/000100022826000013/0001000228-26-000013-index.htm
- HSIC Profile on Yahoo Finance finance.yahoo.com/quote/HSIC
- HSIC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/hsic
